1. Introduction {#sec1}
===============

*Indigofera heterantha* Wall, generally known as *Indigo* Himalayan, is a deciduous shrub distributed in the tropical region of the globe. In Pakistan, 24 species of the genus are available [@bib1]. Natural products such as flavonoids, lignin, alkaloids, steroids, triterpenes and acylphloroglucinols are the main compounds reported from the genus [@bib2]. Other compounds like quinines, saponins, tannins, caffeic acid, gallic acid, rutin, myricetin, quercitrin and galangin were also isolated from the genus *Indigofera*. Some species of the genus contain 3- nitro propionate and other toxic substances, which act as suicide in-activator of succinate dehydrogenase [@bib2]. Various species of the genus *Indigofera* are used for various medicinal purposes. Traditionally, *I. daleoides* is used to cure diarrhea and considered effective againstseveral pathogens. *I. oblongifolia* was found to have antimicrobial [@bib3], hepatoprotective [@bib4]and lipoxygenase inihibition [@bib5] activities. Chemical constituents of *I. pulchra* are effective neutralizer for snake-venom [@bib3], whereas *I. tinctoria* possess free radical scavenging and anti-dyslipidemic activities [@bib6]. The genus indigofera contain Plant sphingolipids a diverse group of lipids composed of polar head groups attached to CERs which contain SBs joined with FA moieties. The structural diversity, physiological roles, and metabolism of plant sphingolipids and glycosphingolipids are well documented \[[@bib7], [@bib8], [@bib9], [@bib10]\]. Extensive characterization of individual species in this complex and diversified class of plant lipids with powerful analytical tools led to the introduction of a new re-search area, sphingolipidomics [@bib9]. Plant sphingolipids play critical roles in membrane stability and permeability, signaling, and cell regulation as well as cell-to-cell interactions \[[@bib8], [@bib10], [@bib11]\] From the literature data reported above it is clear that this genus is comprised of active therapeutic agents that are why the medicinal plant *I. heternatha* wall was selected to explore it phytochemically. In the current study, a novel indigoferamide-A, namely, (S)-2-hydroxy-N-((2S,3S,4R,E)-1,3,4 trihydroxyicos-16-en-2-yl) tricosanamide, isolatedfrom *Indigofera heterantha* [@bib12] was characterized by employing density functional theory calculations and molecular docking. In order to check the significance and medicinal potential of this novel compound it was subjected to various bioassays. These assays included anti-urease and antiglycation.

2. Material and methods {#sec2}
=======================

2.1. Plant material {#sec2.1}
-------------------

The seeds of *Indigofera heterantha* were collected in May 2009 from Northern areas (Lower Dir) of Pakistan. The taxonomic identification of the plant was done by Department of Botany, Islamia College University, Peshawar, Pakistan. The voucher specimen (SJ-36) was deposited in the herbarium of the department.

2.2. Extraction and isolation {#sec2.2}
-----------------------------

Shade-dried powdered seeds (22 kg) were extracted (thrice) with 5% aqueous methanol for seven days. The combined extract was evaporated under reduced pressure to get brownish residue F1 (2.29 kg), which was partitioned between chloroform and water to yield F2 (41 g, chloroform-soluble fraction) and F3 (1.6 kg, water-soluble fraction). The chloroform-soluble fraction (F2) was further partitioned into methanol and *n*-hexane fractions using Soxhlet extractor to afford FR1B (36 g) and FR1A (3 g), respectively. Water soluble fraction was also partitioned with ethyl acetate (EtOAc) to yield ethyl acetate soluble fraction FR3A (1 kg). FR3A was further subjected to fractionation using ether: petroleum ether (2:1) and water to get three fractions, FR3AC (400 g), FR3AB (160 g) and residue fraction FR3AA (360 g). The fraction FR3AC was subjected to column chromatography on silica gel and eluted with *n*-hexane- ethyl acetate in increasing polarity to yield six fractions (1--6). The fractions (3--5) were combined based on thin layer chromatography (TLC) profile and subjected to further column chromatography to yield 73 fractions. The mixed sub-fractions 41--64, were further chromatographed, and eluted with *n*-hexane-acetone in increasing polarity to obtain various sub-fractions. Further separation and purification of these fractions using pre-coated preparative TLC plates resulted in the isolation of one new compound.

2.3. Computational methods {#sec2.3}
--------------------------

All calculations were performed with Gaussian 09 [@bib13]. The geometries were optimized without any symmetry constraints with B3LYP method using 6-31G (d,p) [@bib14] basis set in the gas phase and in methanol. The B3LYP method consists of Becke\'s three-parameter hybrid functional [@bib15] in conjunction with the correlation function of Lee, Yang, and Parr [@bib16]. The B3LYP method is a cost-effective and accurate and works reasonably well for the prediction of geometries of a number of synthetic \[[@bib17], [@bib18], [@bib19]\] and natural products \[[@bib20], [@bib21]\]. Conformational analysis has been performed with B3LYP/6-31G(d,p) without any symmetry constraints around three important dihedral angles; O=C-N-H, N-C2-C3-C4 and O-C2′-C3′-CC4' (See Figure SI-1, supporting information). The aliphatic chains were kept fully stretched during the conformational analysis. The minimum energy conformer was then fully optimized at B3LYP/6-31G(d,p) level of theory. The optimized structure was confirmed by frequency analysis at the same level (B3LYP/6-31G(d,p)) as a true minimum (without any imaginary frequency). The frequency analysis was performed in gas phase and in methanol solvent. Two scaling factors were applied because it is reported recently as an effective approach for accurate vibrational analysis [@bib22]. ^1^H and ^13^C NMR calculations were performed in methanol solvent (MeOH) using GIAO/WP04/6-31 G (d, p) [@bib23]. Polarization continuum model (PCM) [@bib24] approach was applied to study the solvent effect. The reported theoretical chemical shifts are with respect to TMS as an internal standard. Although, the experimental UV-Vis did not reveal any peak in 200--800 nm range, but we have calculated the UV-Vis spectrum with TD- DFT/B3LYP/6-31G(d,p) in order to find the exact absorption maximum. The electronic properties such as electron affinity (E.A.), ionization potential (I.P), band gaps, coefficient of highest occupied molecular orbital (HOMO) and coefficient of lowest unoccupied molecular orbital (LUMO) are also calculated at B3LYP/6-31G(d,p). The band gap is taken as the difference in energies of HOMO and LUMO. Electronic properties such as hardness, softness, electronegativity is calculated from ionization potential and electron affinities using the following equations [@bib25].

2.4. Urease inhibition assay {#sec2.4}
----------------------------

Reaction mixtures, consisting of 25 μL of enzyme (Jack bean ureases) solution and 55 μL of buffers containing 50 mM urea were incubated with 5 μL of test compound at 30 °C for 15 minutes in 96-well plates. Urease inhibition activity was determined by using the indophenol method [@bib26]. Forty-five μL of phenol reagent (1% w/v phenol and 0.005% w/v sodium nitroprussside) and 70 μL of alkali reagent (0.5% w/v NaOH and 0.1% active sodium hypo chloride) were added. The assay was monitored by an increase in absorbance at 560 nm after 10 min, using a microplate reader (Molecular Devices, USA). All reactions were performed in triplicate in a final volume of 200 μL. The results (change in absorbance per minute) were processed by using SoftMax Pro software (Molecular Devices, USA). The assays were performed at pH 6.8. Percent (%) inhibition was calculated by formula 100- (OD test well/OD control) ×100. Thiourea was used as the standard inhibitor of urease.

2.5. In vitro antiglycation assay {#sec2.5}
---------------------------------

In vitro antiglycation activity was examined by incubation of methylglyoxal (14 mM), different concentrations of test compounds (which are prepared in 10 % final DMSO concentration), NaN~3~ (30 mM) in 0.1 M buffer solution (phosphate, pH 7.4), and BSA (10 mg/mL) under aseptic conditions for 9 days at 37 °C. Each sample was observed after 9 days against the sample blank for the specific fluorescence (excitation: 330 nm; emission: 440 nm) development [@bib27]. The positive control was rutin. The % inhibition for each compound (formation of AGE) versus control was determined by using the following formula: % inhibition = (1-Fluorescence of test sample/Fluorescence of the control group) × 100 Rutin and methylglyoxal (MG) (40 % aqueous solution) were purchased from Sigma-Aldrich (Japan), BSA (Bovine Serum Albumin) from Merck Marker (Germany), and disodium hydrogen phosphate (Na~2~HPO~4~), sodium azide (NaN~3~) and sodium dihydrogen phosphate (NaH~2~PO~4~) from Scharlau Chemie, S. A. (Spain), while dimethyl sulphoxide (DMSO) was from Fischer Scientific (UK).

2.6. Molecular docking {#sec2.6}
----------------------

To predict the bioactive conformations, the indigoferamide was docked into the binding pockets of the selected proteins (enzymes) by using the default parameters of MOE-Dock program. Before docking the ligands into protein molecules, MOE 2009-10 Build program (which is implemented in MOE) was used to sketch the isolated compound. Energy minimization was carried out up to 0.05 gradients by using MMFF94x force field through the default parameter of MOE energy minimization algorithm. The protein molecules of urease (PDB ID code: 4UBP) and α-glucosidase (PDB ID code: 3NO4) were downloaded from Protein Data Bank having resolutions of 1.55Å and 2.02Å respectively. All water molecules were removed from the receptor proteins and 3D protonation was carried out by using Protonate 3D Option. The energies of protein molecules were minimized by using the default parameters of MOE 2009-10 energy minimization algorithm (gradient: 0.05, Force Field: MMFF94X). Then, all the ligands were docked into the binding pockets (selective residues/amino acids) of the above proteins using default parameters of MOE-Dock Program. Re-docking procedure was also applied to validate the accuracy of docking protocol [@bib28]. After docking, all the complex images were analyzed for specific types of interactions; bond lengths and their 3D images were taken.

3. Results and discussions {#sec3}
==========================

3.1. Supporting spectral data of indigoferamide-A {#sec3.1}
-------------------------------------------------

Indigoferamide-A was earlier isolated as colorless powder [@bib12]. The molecular formula C~43~H~85~NO~5~ was inferred from HR-FABMS which showed molecular ion (Pseudo) \[M+H\]^+^ peak at m/z 696.6806 (calcd. for C~43~H~86~NO~5~; 696.6760) ([Fig. 1](#fig1){ref-type="fig"}). The structure was confirmed based on mass fragments ([Fig. 2](#fig2){ref-type="fig"}) in the EIMS at m/z 281 \[M ^+^-C~23~H~44~NO~5~\], 368 \[M^+^-C~20~H~39~O~3~\], 223 \[M^+^-C~27~H~55~NO~5~\], 69 \[M^+^-C~38~H~77~NO~5~\] and 43 \[M^+^-C~40~H~79~NO~5~\]. Optical rotation of the compound was \[α\] ^27^: -16. The IR spectrum exhibited absorption bands at 3475 (OH), 3340 (amide group), 1664 (C = O), 2924, 2854 cm^−1^ (aliphatic) which illustrated the presence of an amide fatty acid [@bib29]. The ^1^H NMR spectrum ([Table 1](#tbl1){ref-type="table"}) of Indigoferamide-A showed three oxygenated methine multiplet signals at *δ*~H~3.55, 3.52 and 4.02 for H-3, H-4 and H-2', respectively, and a downfield nitrogenated methine multiplet at *δ*~H~ 4.10 for H-2. A doublet at *δ*~H~ 3.74 (*J* = 5 Hz, H-1) was assigned to the oxygen bearing methylene group. The two terminal methyl protons (H-20 and H-23′) appeared as triplets at *δ*~H~ 0.89 (*J* = 7 Hz, 6H). The characteristic resonances in the ^1^H and ^13^C NMR spectra ([Table 1](#tbl1){ref-type="table"}) at 176.9/8.56 (C-1′/N-H), 62.1/3.74 (C-1/H-1) and *δ*~C~*/δ*~H~ 52.9/4.10 (C-2/H-2) confirmed the cerebroside skeleton [@bib30]. The characteristic chemical shifts at δ~*C*~ 32.7--33.1 of the methylene carbons adjacent to the double bonds indicated the *E* geometry around the double bond (δ~*C*~ 26--28 for *Z*-geometry) \[[@bib31], [@bib32]\]. ^1^H NMR spectrum was of little significane in assigning the *E*-stereochemistry due to the multiplets observed for H-16 and H-17. The NH proton (*δ*~H~ 8.56) showed HMBC correlation ([Fig. 3](#fig3){ref-type="fig"}) with carbonyl carbon (*δ*~C~ 176.9, C-1′) and a methine carbon (*δ*~C~ 52.9, C-2) which inidcated an amide linkage. The ^1^H-^1^H COSY correlation ([Fig. 3](#fig3){ref-type="fig"}) of indigoferamide-A can be demonstrated as H-22′/H-23′, then H-2′/H-3′/H-4′and H-1/H-2/H-3/H-4/H-5/H-6. Comparison of ^13^C NMR resonances with reported compounds helped in identifying the stereochemistry at chiral centers \[[@bib33], [@bib34]\].Fig. 1Numbering scheme of indigoferamide A.Fig. 1Fig. 2Key EI MS fragmentation in indigoferamide A.Fig. 2Table 1^1^H (600 MHz) and ^13^C NMR (150 MHz) spectral data of indigoferamide A in MeOD.Table 1C. No.^1^H NMR ~*H*~ (*J* in Hz)^13^C NMR ~C~MultiplicityHMBC13.74, (d, *J* = 5)62.0CH~2~C-324.10, m52.9CHC-1′33.55, m76.0CH\--43.52, m73.2CHC-2, C-551.28, m33.8CH~2~\--6--71.28, m27.2CH~2~\--8--131.28, m30.5CH~2~\--141.28, m33.7CH~2~\--151.28, m33.1CH~2~\--165.43, m131.6CHC-15175.45, m131.6CH\--181.28, m32.7CH~2~C-17191.28, m23.8CH~2~\--200.89, (t, *J* = 7)14.5CH~3~C-181′\--176.9-C\-\--2′4.02, m72.9CHC-1′, C 3′3′1.61, m35.8CH~2~\--4′, 5′1.28, m30.5CH~2~\--6′, 20'1.28, m30.5CH~2~\--21'1.28, m33.8CH~2~\--22'1.28, m23.8CH~2~\--23'0.89, (t, *J* = 7)14.5CH~3~\--NH8.5, s\-\-\-\-\--Fig. 3Key HMBC correlations of indigoferamide A.Fig. 3

3.2. Conformational analysis {#sec3.2}
----------------------------

DFT calculations have been performed to gain insight into the structure and spectroscopic properties of indigoferamide A. The correlation of the experimental and theoretical spectroscopic data supports the assigned structure. Conformation analyses have been performed at B3LYP/6- 31G(d,p). Three important dihedral angles were selected, and a series of conformers were obtained by rotation around these angles. First, different conformers were obtained at 10° rotation around O=C-N-H dihedral angle, and a plot of energies of conformers as a function of dihedral angle is shown in the supporting information (Fig. SI1). The lowest energy conformer was obtained at a dihedral angle of -177°. This rotation generates favourable nonbonding interaction of the hydrogen on C1 with the carbonyl oxygen. Next, the conformational analysis was performed by rotation around C2-C3 bond (NH-C2-C3-C4 dihedral angle). This rotation does not produce any conformer with the energy lower than the obtained from the above step (Fig. SI2). This rotation causes steric interaction between both aliphatic chains as they approach each other during the process. Next, rotation was performed around OH-C2′-C3′-C4′, and relative energy with respect to degree of rotation was analysed. The authors again could not locate any conformer with energy lower than the starting conformer (Fig. SI3). Some other important dihedral angles have been identified (for example, C2-C3- C4-C5); however, conformational analyses have not been performed around these bonds because such analyses would break the existing hydrogen bonding interactions and would definitely lead to increase in energy. Moreover, the aliphatic chains are fully stretched, and we had found that any rotation of the aliphatic chain (to form bent structure) would increase the energy of the conformer. The lowest energy conformer was fully optimized at B3LYP/6-31G(d,p). The geometry was also optimized in methanol and chloroform solvents. The optimized geometry is shown in ([Fig. 4](#fig4){ref-type="fig"}). C2-OH proton is a hydrogen bond donor to carbonyl oxygen at the distance of 1.94Å. The carbonyl oxygen also has nonbonding dipole type interactions with the hydrogen on C-3 (2.55Å). The amide nitrogen acts as a hydrogen bond acceptor from the hydroxyl on C1. Hydroxy moieties on C3 and C4 also have hydrogen bonding type interactions between them. The hydroxyl of C3 acts as a hydrogen bond donor to the oxygen of C4. Some important bond lengths and angles are shown in the ([Table 2](#tbl2){ref-type="table"}).Fig. 4Optimized geometry of indigoferamide A at B3LYP/6-31G(d,p).Fig. 4Table 2Selected optimized geometric parameters of indigoferamide A, calculated at B3LYP/6- 31G\* in the gas phase (refer to [Fig. 1](#fig1){ref-type="fig"} for numbering scheme).Table 2AtomsBond lengths (Å)AtomsAngle (degrees)C=O1.23O=C1-N124.13C-N1.36C15-C16-C17125.47C1'-O1.42C2-N-C1′124.39C2-O1.43Dihedral angles (degrees)C3-O1.44O-C4-C3-O-57.62C1'-O1.41O-C1-C2-N-56.95C=C1.34O=C-N-C10.58O-C1-C1' = O-12.98

3.3. Infra-red spectral analysis {#sec3.3}
--------------------------------

The experimental IR spectrum of indigoferamide A shows prominent peaks for olefinic C-H, aliphatic C-H, amide CO, alkene C=C stretching vibration in the functional group region as well as NH and C-H bending vibrations. The IR spectrum is also simulated at B3LYP/6-31G(d,p), and compared with the experimental spectrum. Two scaling factors are applied to the vibrational frequencies [@bib22] for better correlation with the experimental results; frequencies above 1800 cm^−1^ are scaled with 0.9648 [@bib35] whereas frequencies below 1800 cm^−1^ are scaled with 0.992. The amide NH stretching vibration is theoretically predicted to appear at 3492 cm^−1^, which is slightly higher than the experimental 3340 cm^−1^. This is probably attributed to the condensed phase nature of the molecules in the experimental IR spectrum. Two important simulated stretching vibrations of C- H bonds on olefinic moieties are; 3001 and 2996 cm^−1^, for *anti*-symmetric and symmetric stretching of the alkene C-H bonds, respectively. The simulated C-H stretching vibrations for aliphatic protons were observed as a broad peak at 2990 cm^−1^. The olefinic C=C and amide C=O stretching are simulated at 1680 and 1670 cm^−1^. Both the vibrations were observed experimentally as a relatively broad peak at 1664 cm^−1^, which shows the nice correlation between theoretical and experimental values. The N-H bending vibration was simulated at 1498 cm^−1^, whereas the C-H bending vibrations at 1413 cm^−1^. The C-O stretching vibrations are observed at 1252 cm^−1^([Table 3](#tbl3){ref-type="table"}).Table 3Comparison of experimental and theoretical vibrational frequencies of indigoferamide in gas and methanol solvent and their assignment.Table 3Wavenumber (Expt)\
cm^−1^Wavenumber (Unscaled)\
cm^−1^Wavenumber (Scaled)\
cm^−1^Wavenumber (Unscaled)\
cm^−1^Wavenumber (Scaled)\
cm^−1^Approximate AssignmentGasMethanol3838370338283694υ (OH)34753804367037963662υ (OH)3780364737613628υ (OH)3640351236333505υ (OH)33403626349836203492υ (NH)3124301431213011υ (CH)3112300231183008υ (CH~2~)3111300131082999υ (CH~3~)3110300131062997υ (CH~3~)3106299731032993υ (CH~2~-CH~3~)3105299631002991υ (CH~2~-CH~3~)3096298730952986υ (CH~2~)3093298430892980υ (CH~2~)29243079297130862977υ (CH~2~) *Antisym.*3078297030712963υ (CH~2~)3073296530692961υ (CH~2~)3072296430692961υ (CH~2~-CH~3~)3063295530602952υ (CH~2~)3058295030512943υ (CH~2~)3038293130392932υ (CH~2~)3037293030372930υ (CH~3~)3030292330292922υ (CH~2~)3027292030282922υ (CH~2~)28543004289830062900υ (CH~2~)2991288630032897υ (CH) Aliphatic2981287630022896υ (CH) Aliphatic16641748173417291715υ (C=O)166417371723υ (C=C)1552154015631551δ (NH), δ (CH)1459144714461434ω (CH~2~) δ (OH)1451143914351424ω (CH~2~) δ (OH)14361425ω (CH~2~)1404139314021391ω (CH~2~)1323131213181308γ (CH~2~) ρ(CH~2~)1303129313011290γ (CH~2~) υ (C-O)1296128612981287δ (OH), δ (CH)1233122312301220δ (OH), δ (CH)1120111111151106υ (CC), υ (CO)1092108310861077υ (CC), υ (CO))1084107510821073υ (CC), υ (CO)

3.4. UV-Vis analysis {#sec3.4}
--------------------

The experimental UV-Vis analysis of the indigoferamide A did not reveal any absorption band above 200 nm which was consistent with the proposed structure of the compound. The UV-Vis spectra of indigoferamide A was simulated to find the position of the maximum wavelength of absorption. The theoretical spectrum was calculated in methanol solvent at TDDFT (B3LYP/6- 31G(d,p). The theoretical UV-Vis spectrum is shown in [Fig. 5](#fig5){ref-type="fig"} whereas as wavelengths of excitations along with oscillator strength (ƒ) are given in [Table 4](#tbl4){ref-type="table"}. Analysis of the orbitals indicate that the transition corresponds to π- π\*. Analysis of the energies of molecular orbital reveals that the transition corresponding to λ ~max~ is due to excitation from highest occupied molecular orbital (HOMO) to lowest unoccupied molecular orbital (LUMO).Fig. 5Simulated UV Vis spectra of indigoferamide A in methanol, calculated at TD-DFT B3LYP/6-31G(d,p).Fig. 5Table 4Wavelengths, energies and oscillator strengths of excitation in UV-Vis spectrum of indigoferamide A calculated at TD-DFT B3LYP/6-311G(d,p).Table 4nmeVTheoreticalOscillator Strength (ƒ~o~)11886.570.100921816.840.012531776.990.878741737.160.01851657.520.124361567.920.436

The analysis of HOMO and LUMO ([Fig. 6](#fig6){ref-type="fig"}) shows that the charge density in HOMO is mainly localized on the olefinic moiety of indigoferamide A, whereas LUMO is localized on the amide part of the compound. HOMO to LUMO excitation is actually a charge transfer from olefin to amide moiety [@bib36]. The HOMO LUMO gap was found to be 6.64 eV. This band gap is consistent with the excitation at 188 nm (6.57 eV). The high value of the band gap is indicative of the stability of the molecule. The energy of HOMO describes the ability of a compound to donate electron whereas the energy of the LUMO describes the ability of a compound to accept electron. Therefore, both HOMO and LUMO deliver useful information about oxidation and reduction abilities of the compound. The HOMO of indigoferamide A has energy of -6.44 eV, whereas the LUMO has energy of 0.2 eV. The very high value of HOMO illustrates the stability of the compound against oxidation [@bib37]. The HOMO-LUMO band gap for the compound is 4.42 eV.Fig. 6HOMO and LUMO of indigoferamide A, calculated at B3LYP/6-31G(d,p). The orbitals are plotted at isodensity of 0.06.Fig. 6

3.5. Electronic properties {#sec3.5}
--------------------------

We have calculated the electronic properties at B3LYP/6-31G(d,p) on the optimized geometry of indigoferamide A. Electronic properties are not studied experimentally for indigoferamide A, but they reveal useful information regarding stability and activities of a compound [@bib27]. According to Koopmans theorem [@bib38], energies of HOMO and LUMO can be approximately taken equivalent to ionization energy and electron affinity, respectively (vide supra). The HOMO in the compound has energy of -6.44 eV whereas the LUMO has energy of +0.20 eV which lead to the band gap of 6.64 eV. The very high band gap for the compound indicates its high stability. The ionization potential and electron affinities for the compound are 6.44 and -0.2 eV, respectively. Other electronic properties such as hardness, softness and electronegativity are calculated using the Eqs. [(3)](#fd3){ref-type="disp-formula"}, [(4)](#fd4){ref-type="disp-formula"}, and [(5)](#fd5){ref-type="disp-formula"} given in the section of computational methods. Electronegativity, hardness and softness of the indigoferamide A are 3.32, 3.12 and 0.160 eV, respectively.

3.6. NMR analysis {#sec3.6}
-----------------

The ^1^H NMR spectrum of indigoferamide A was experimentally measured in MeOD on a 500 MHz spectrometer. The theoretical NMR is also calculated using Cramer re-parameterized WP04 functions at B3LYP/6-31G(d,p) in chloroform. The NMR was calculated using GIAO formalism, and the solvent effect was introduced through polarizable continuum model (PCM). NMR was calculated for all conformers lying within 2 kcal range of the minimum energy conformer, and the overall theoretical spectrum is Gaussian weighted average over all conformers. Although different conformers were taken into account; however, no significant differences could be observed between different conformers. A comparison of the theoretical ^1^H and ^13^C NMR chemical shifts with the experimental values is given in ([Table 5](#tbl5){ref-type="table"}). As it can be seen in the ([Table 4](#tbl4){ref-type="table"}), theoretical^1^H NMR chemical shifts of the compound correlate nicely with the experimental chemical shifts without any scaling factor. Similarly, the calculated ^13^C NMR chemical shifts of indigoferamide A also correlate adequately with the experimental chemical shift values.Table 5Comparative theoretical and experimental ^1^H and ^13^C NMR chemical shifts for indigoferamide A.Table 5^1^H Chemical shifts (coupling constant)^13^C chemical shiftsExperimental\`TheoreticalExperimentalTheoretical13.74, (d, *J* = 5)3.9662.060.9924.10, m3.2852.966.4033.55, m4.9576.072.9843.52, m1.8573.276.3051.28, m1.6533.831.326-71.28, m1.6027.230.128-131.28, m1.6030.534.7141.28, m1.7333.735.26151.28, m2.2333.137.68165.43, m5.90131.6125.38175.45, m5.82131.6125.99181.28, m2.3532.738.56191.28, m1.7323.828.95200.89, (t, *J* = 7)1.3814.517.361′\--176.9170.842′4.02, m4.0372.974.793′1.61, m1.5735.841.824′, 5′1.28, m1.6030.530.02,34.696′, 20'1.28, m1.6030.534.621'1.28, m1.6033.836.122'1.28, m1.6023.826.9623'0.89, (t, *J* = 7)1.3814.518.26NH8.5, s\--

3.7. Urease activity {#sec3.7}
--------------------

Urease plays significant role in plant nitrogen metabolism \[[@bib36], [@bib37]\]. Urease has been recognized as a virulence factor as it participates in the development of kidney stones, pyelonephritis, peptic ulcers, and other diseases \[[@bib39], [@bib40]\]. The search of effective and safe urease inhibitors is very important area of pharmaceutical research \[[@bib41], [@bib42], [@bib43]\]. In continuation of our efforts to discover new and potent inhibitors of medicinally important enzymes through high-throughput screening assays, we identified this compound, having considerable efficacy against ureases ([Table 6](#tbl6){ref-type="table"}). From the docking results it was clear that the indigoferamide was strongly bound in the active site of urease by making two strong interactions with His324 and Asp224 amino acid residues as shown in ([Fig. 7](#fig7){ref-type="fig"}). The first strongest side chain donor interaction was found between His324 and OH group of the long chain with a bond distance of 2.14 angstrom. Asp224 showed strong side chain accepter interaction with hydrogen atom of OH group of long chain having a bond length of 2.22 angstrom. Some other residues like Glue166, Glu223 and His323 were also present in the nearby vicinity.Table 6Urease activity exhibited by indigoferamide A.Table 6S. NoConcentration (μM)% InhibitionIC~50~ (μM) ± S. E. M(Indigoferamide A)100029323.21 ± 1.9Thiourea10008321.01 ± 0.1[^1]Fig. 72D (A) and 3D (B) docking interaction images of indigoferamide A with the active pocket of urease.Fig. 7

3.8. Antiglycogen activity {#sec3.8}
--------------------------

The same compound was docked into the binding pockets of α-glucosidase. The compound showed promising antiglycogen activity ([Table 7](#tbl7){ref-type="table"}). From the 2D and 3D interaction images, it was clear that Thr172 showed a strong single side chain acceptor interaction with OH group of the long hydrocarbon chain of the indigoferamide. It has given a bond distance of 2.26 Å as shown in the ([Fig. 8](#fig8){ref-type="fig"}). Trp169, Arg168 and Gly170 were also present in the nearest region.Table 7Antiglycation activity of indigoferamide A.Table 7S. NoCompoundsConcentration (μM)% InhibitionIC50 (μM) ± S. E. M1 (Indigoferamide A)1100040NA3. Rutin2100083289.1 ± 0.3[^2]Fig. 82D (A) and 3D (B) interaction images of indigoferamide A with the active pocket of Alpha glucosidase.Fig. 8

4. Conclusions {#sec4}
==============

The indigoferamide-A, isolated from *Indigofera heterantha* was characterized by modern spectroscopic analytical techniques. DFT calculations of the compound have been performed at B3LYP/6-31G(d,p) level for obtaining geometries and spectroscopic properties of indigoferamide-A. Conformational analyses have been performed to locate the lowest energy conformer. The vibrational spectrum of the compound, simulated at B3LYP/6-31G (d,p) shows nice correlation with the experimental IR spectrum through a scaling factor of 0.9648. Analysis of UV-Vis spectrum and HOMO and LUMO illustrated that the transition corresponding to the maximum wavelength is a transition from HOMO to LUMO. ^1^H and ^13^C NMR was calculated using Cramer\'s reparameterized function WP04 at 6-31G(d,p) basis set. Although different conformers were considered for the calculation of chemical shifts; however, no significant differences were observed among these conformers. Electronic properties such as band gap, ionization potential, electronegativity, electron affinities, softness and hardness were also simulated for the first time; however, no comparison could be made with the experiment. The indigoferamide A was screened for urease and antiglycation activities. The compound showed good activity against urease enzyme. Molecular docking simulations reveal useful information regarding the binding of indigoferamide-A with the urease enzyme.
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Appendix A. Supplementary data {#appsec1}
==============================

The following is the supplementary data related to this article:Original Manuscript_V2.docx \[29--37\]Conformational analysis and optimized geometry of indigoferamide A in gas phase and methanol solvent are shown in the supplementary informationOriginal Manuscript_V2.docx \[29--37\]

[^1]: S. E. M. = Standard error of the mean of five assays \* = Standard inhibitor for urease assay.

[^2]: S. E. M. = Standard error of the mean of five assays \* = Standard inhibitor for antiglycation bioassay.
